Elsevier

Heart Rhythm

Volume 16, Issue 8, August 2019, Pages e66-e93
Heart Rhythm

News From the Heart Rhythm Society
2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

https://doi.org/10.1016/j.hrthm.2019.01.024Get rights and content

Keywords

ACC/AHA Clinical Practice Guidelines
Focused update
Acute coronary syndrome
Anticoagulants
Anticoagulation agents
Antiplatelet agents
Apixaban
Atrial fibrillation
Atrial flutter
Cardioversion
Coronary artery disease
Coronary heart disease
Stents
Dabigatran
Edoxaban
Hypertension
Idarucizumab
Myocardial infarction
Obesity
Percutaneous coronary intervention
Risk factors
Rivaroxaban
Sleep apnea
Stroke
Thromboembolism
Warfarin

Cited by (0)

Developed in collaboration with the Society of Thoracic Surgeons.

This document was approved by the American College of Cardiology Clinical Policy Approval Committee, the American Heart Association Science Advisory and Coordinating Committee, and the Heart Rhythm Society Board of Trustees in September 2018, and the American Heart Association Executive Committee in January 2019.

The Heart Rhythm Society requests that this document be cited as follows: January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm 2019;16:e66–e93.

This article has been copublished in the Journal of the American College of Cardiology and Circulation.

Copies: This document is available on the websites of the American College of Cardiology (www.acc.org), the American Heart Association (professional.heart.org), and the Heart Rhythm Society (www.hrsonline.org). For copies of this document, please contact the Elsevier Inc. Reprint Department via fax (212-633-3820) or e-mail ([email protected]).

Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the Heart Rhythm Society. Requests may be completed online via the Elsevier site (http://www.elsevier.com/about/policies/author-agreement/obtaining-permission).

Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information.

ACC/AHA Task Force on Clinical Practice Guidelines Liaison.

ACC/AHA Representative.

HRS Representative.

§

STS Representative.

ACC/AHA Task Force on Performance Measures Representative.

#

Former Task Force member; current member during the writing effort.

View Abstract